急性缺血性卒中；白细胞；预后。
缺血性卒中；尿激酶；超声溶栓。
缺血性卒中的发病率远高于出血性卒中。
The attack rate of cerebral arterial thrombosis was far superior to that of hemorrhagic stroke.
缺血性卒中的溶栓治疗已经受到广泛的关注。
Thrombolytic therapy for ischemic stroke has received wide attention.
目的分析缺血性卒中患者颅内外动脉狭窄的分布。
Objective To analyze distribution of intracranial and extracranial arteriostenosis in patients with ischemic stroke.
近年来，缺血性卒中的新的危险因素在不断提出。
Some new risk factors for ischemic stroke are being advanced in recent years.
急性缺血性卒中的溶栓治疗是目前医学研究的热点。
Thrombolytic therapy for acute ischemic stroke is a hotspot in current medical study.
急性缺血性卒中患者，推荐不用链激酶(1a级)。
For patients with acute ischemic stroke, we recommend against streptokinase (Grade 1a).
抗血小板药在缺血性卒中防治中的作用已得到公认。
The roles of antiplatelet agents in the prevention and treatment of ischemic stroke has been well accepted.
神经保护药治疗急性缺血性卒中：有效还是无效?。
Neuroprotective Agents for Acute Ischemic Stroke:Effective or Non-effective?
基底动脉尖缺血性卒中的昏迷：是不可逆性昏迷吗？
Coma from "Top of the Basilar Artery" Ischemic Stroke: Is Irreversible Coma?
最主要的入选标准是以缺血性卒中为基本诊断而收治者。
The major inclusion criterion was admission to an acute carefacility with a principal diagnosis of ischemic stroke.
国际循环：应该怎样易化缺血性卒中患者的快速评价手段？
International Circulation: How should the rapid evaluation of ischemic stroke patients be facilitated?
缺血性卒中患者的病情恶化——是采取新的策略的时候了吗？
Worsenig in ischemic stroke patients: is it time for a new strategy?
研究背景：主动脉弓处动脉粥样斑块是缺血性卒中的危险因素。
Background: Atherosclerotic plaques in the aortic arch are a risk factor for ischemic stroke.
目的：探讨进展性缺血性卒中的危险因素，为其预防提供依据。
Objectives: To explore the risk factors of progressive ischemic stroke and to provide bases for its prevention.
在急性缺血性卒中这种多基因方法显示了其现场即时检验的潜力。
This multigene approach shows potential for a point-of-care test in acute ischemic stroke.
目的：研究首乌仙海片激活下调脑区治疗缺血性卒中的作用机制。
Objective:To study the action mechanism of shouwuxianhai tablets ischemic cerebrovascular disease from the activation cerebral area of functional down-regulation.
目的探讨脑急性缺血性卒中患者动脉内溶栓治疗的安全性和有效性。
Objective To evaluate the safety and efficacy of intra - arterial fibrinolysis for acute thrombosis of cerebral vessels.
结果：研究共纳入82名患者，77名有缺血性卒中，5名有脑内出血。
Results: A total of 82 patients were included, 77 with ischemic stroke and 5 with intracerebral hemorrhage.
出血性卒中致死的风险上升61%，缺血性卒中致死的风险增加2.43倍。
Hemorrhagic stroke death risk was increased by 61 percent. The risk of ischemic stroke death was increased 2.43 times.
近年来的研究发现，缺血性卒中后aqp4与PKC的表达呈现一定的相关性。
In recent years, studies have found that there is a certain correlation between the expressions of AQP4 and PKC after ischemic stroke.
急性缺血性卒中的致残率很高，改善或维护患者的神经功能是治疗的最终目的。
The disability rate of acute ischemic stroke(AIS) is very high, improve and maintain neurological function is the ultimate objective.
目的：探讨无心房颤动的缺血性卒中患者抑郁状态与血管危险因素之间的关系。
Objective: to determine the relationship between post-stroke depression (PSD) and vascular risk factors in a well-defined ischemic stroke cohort.
老年缺血性卒中在病因病机、治疗方法等方面迥异于老年前期缺血性卒中患者。
Senile ischemic apoplexy completely differs from senile prophase ischemic apoplexy in etiology and pathogenesis as well as in therapeutic methods.
治疗前MRI评分系统是否影响急性缺血性卒中溶栓治疗的安全性及有效性?。
Do Pretreatment MRI Scoring Systems Affect the Safety and Efficacy of Thrombolytic Therapy for Acute Ischemic Stroke?
血管内机械再通作为一种新的治疗手段，现已成为急性缺血性卒中的重要治疗方法和研究热点。
As a novel modality of primary treatment, endovascular mechanical recanalization using clot removal has become a noticeably efficient intervention and a hot research focus of acute ischemic stroke.
前言：目的：探讨复健片对缺血性卒中后遗症模型大鼠星形胶质细胞活性及其神经轴突再生的作用。
Objective: To explore effects of Fujian Tablets on activity of astrocytes and axonal regeneration in the ischemic stroke sequela model rat.
前言：目的：探讨复健片对缺血性卒中后遗症模型大鼠星形胶质细胞活性及其神经轴突再生的作用。
Objective: To explore effects of Fujian Tablets on activity of astrocytes and axonal regeneration in the ischemic stroke sequela model rat.
应用推荐